Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Camp4 Therapeutics (CAMP) EPS (Weighted Average and Diluted): 2023-2024

Historic EPS (Weighted Average and Diluted) for Camp4 Therapeutics (CAMP) over the last 2 years, with Dec 2024 value amounting to -$11.04.

  • Camp4 Therapeutics' EPS (Weighted Average and Diluted) rose 97.73% to -$0.55 in Q3 2025 from the same period last year, while for Sep 2025 it was $63.67, marking a year-over-year increase of 159.54%. This contributed to the annual value of -$11.04 for FY2024, which is 91.15% up from last year.
  • Latest data reveals that Camp4 Therapeutics reported EPS (Weighted Average and Diluted) of -$11.04 as of FY2024, which was up 91.15% from -$124.80 recorded in FY2023.
  • Camp4 Therapeutics' 5-year EPS (Weighted Average and Diluted) high stood at -$11.04 for FY2024, and its period low was -$124.80 during FY2023.
  • Moreover, its 2-year median value for EPS (Weighted Average and Diluted) was -$67.92 (2023), whereas its average is -$67.92.
  • Data for Camp4 Therapeutics' EPS (Weighted Average and Diluted) shows a peak YoY spiked of 91.15% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Camp4 Therapeutics' EPS (Weighted Average and Diluted) stood at -$124.80 in 2023, then skyrocketed by 91.15% to -$11.04 in 2024.